VolitionRx (VNRX) Insider Trading & Ownership $0.66 +0.01 (+2.20%) As of 12:44 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock VolitionRx (NYSE:VNRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$462.59KNumber OfInsiders Selling(Last 12 Months)0 Get VNRX Insider Trade Alerts Want to know when executives and insiders are buying or selling VolitionRx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VNRX Insider Buying and Selling by Quarter VolitionRx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/12/2025Cameron John ReynoldsCEOBuy15,000$0.66$9,900.00 8/5/2025Cameron John ReynoldsCEOBuy78,125$0.64$50,000.00 8/5/2025Guy Archibald InnesDirectorBuy78,125$0.64$50,000.00 6/12/2025Cameron John ReynoldsCEOBuy12,500$0.59$7,375.00 6/3/2025Guy Archibald InnesDirectorBuy20,000$0.54$10,800.00 5/19/2025Cameron John ReynoldsCEOBuy20,000$0.44$8,800.00 5/19/2025Jacob Vincent MicallefInsiderBuy50,000$0.43$21,500.00 3/26/2025Cameron John ReynoldsCEOBuy181,818$0.55$99,999.90 12/9/2024Cameron John ReynoldsCEOBuy139,811$0.57$79,692.27 12/9/2024Guy Archibald InnesDirectorBuy174,764$0.57$99,615.48 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/9/2024Jacob Vincent MicallefInsiderBuy43,691$0.57$24,903.87 (Data available from 1/1/2013 forward) VNRX Insider Trading Activity - Frequently Asked Questions Who is on VolitionRx's Insider Roster? The list of insiders at VolitionRx includes Cameron John Reynolds, Corp Ltd Eight, Gaetan Michel, Guy Archibald Innes, Jacob Vincent Micallef, Martin Charles Faulkes, Phillip Barnes, Rodney Gerard Rootsaert, and Salvatore Thomas Butera. Learn more on insiders at VNRX. What percentage of VolitionRx stock is owned by insiders? 10.40% of VolitionRx stock is owned by insiders. Learn more on VNRX's insider holdings. Which VolitionRx insiders have been buying company stock? The following insiders have purchased VNRX shares in the last 24 months: Cameron John Reynolds ($262,467.17), Guy Archibald Innes ($298,115.48), Jacob Vincent Micallef ($46,403.87), Rodney Gerard Rootsaert ($6,000.00), and Salvatore Thomas Butera ($24,100.00). How much insider buying is happening at VolitionRx? Insiders have purchased a total of 1,063,834 VNRX shares in the last 24 months for a total of $637,086.52 bought. Which VolitionRx insiders have been selling company stock? The following insider sold VNRX shares in the last 24 months: Corp Ltd Eight ($33,000.00). How much insider selling is happening at VolitionRx? Insiders have sold a total of 40,000 VolitionRx shares in the last 24 months for a total of $33,000.00 sold. VolitionRx Key ExecutivesDr. Martin Charles Faulkes Ph.D. (Age 80)Executive Chairman Compensation: $239.51kMr. Cameron Reynolds MBA (Age 53)Founder, CEO, President & Director Compensation: $572.43kDr. Gaetan Michel Ph.D. (Age 50)Chief Operating Officer Compensation: $518.15kDr. Salvatore Thomas Butera DVM (Age 72)Chief Executive Officer of Volition Veterinary Diagnostics Development LLC Compensation: $477.25kMr. Terig Hughes (Age 53)CFO & Treasurer Compensation: $338.74kDr. Jacob Vincent Micallef MBA (Age 68)Ph.D., Chief Scientific Officer Compensation: $571.55k1 recent tradesMr. Nicholas Plummer (Age 53)Group General Counsel Ms. Louise Batchelor Day (Age 52)Group Chief Marketing & Communications Officer Mr. Thomas BygottSales & Marketing DirectorMr. Gael Forterre M.B.A. (Age 42)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies KYTX Insider Selling LFCR Insider Selling NGNE Insider Selling FENC Insider Selling DBVT Insider Selling VYGR Insider Selling LYEL Insider Selling AVTE Insider Selling PBYI Insider Selling RNAC Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Marvell Insiders Buy Shares—Should Investors Follow Suit?Insider Sales Jump at Broadcom and CoreWeave: Red Flag Ahead?Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t WorryTop Insider Buys and Sells From September: Buy, Sell, or Hold?NuScale, Rocket Lab Face Heavy Insider Selling After Surges This page (NYSE:VNRX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VolitionRx Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share VolitionRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
